QCM
IONS icon

QRG Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

QRG Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Sell
3,079
-15
-0.5% -$1.13K ﹤0.01% 1112
2026
Q1 		$232K Buy
+3,094
New +$244K ﹤0.01% 1051

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

QRG Capital Management's IONS Position: Q2 2026 in Review

QRG Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 0.48% in Q2 2026, selling an estimated $1.13K and leaving 3,079 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

QRG Capital Management first reported a position in IONS in Q1 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • QRG Capital Management held 3,079 shares of Ionis Pharmaceuticals worth $244K as of Q2 2026.
  • QRG Capital Management sold 15 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.13K.
  • Ionis Pharmaceuticals made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #1112 holding.
  • QRG Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.